Welcome to our dedicated page for Aimfinity Investment I SEC filings (Ticker: AIMTF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aimfinity Investment Corp. I filings document the regulatory record of a SPAC issuer, including 8-K material events, shareholder voting matters, redemption mechanics, governance actions, and capital-structure disclosures for its OTC-traded AIMTF security. The filings also cover SPAC security-structure topics associated with a blank-check company, including trust-account and public-share redemption provisions when addressed in formal disclosures.
Its SEC record includes periodic-reporting obligations and Form 12b-25 notices for delayed annual and quarterly reports, alongside material-event filings that record agreements, shareholder-meeting matters, operating and financial reporting, and other disclosures tied to the company’s SPAC status.
Aimfinity Investment Corp. I is asking shareholders to approve a charter amendment that would extend its period to complete a business combination to October 28, 2025 and permit the Board, at the Sponsor's request, to approve up to nine additional one-month extensions through July 28, 2026. The company entered into a Merger Agreement with Docter Inc. that contemplates a reincorporation merger into a Cayman Islands PubCo and an acquisition merger resulting in PubCo as the surviving public company.
The proxy explains redemption mechanics: public shareholders may redeem shares for a pro rata cash amount from the Trust Account (including interest) if the Charter Amendment is approved, with attached Class 2 warrants forfeited on redemption. The filing discloses Trust Account funding from the IPO (gross proceeds cited at $80.5 million and $82,110,000 placed in trust) and that an F-4 related to the Docter Business Combination was declared effective by the SEC.
Aimfinity Investment Corp. I entered into a new unsecured promissory note of $55,823.8 on September 28, 2025 with I-Fa Chang, the designee of its sponsor, to fund a required deposit into its trust account.
This deposit of $55,823.8 equals $0.05 per public share for a one-month extension and allows Aimfinity to extend the deadline to complete its business combination with Docter Inc. from September 28, 2025 to October 28, 2025. This is the last of up to nine monthly extensions permitted under its charter.
Under an exchange agreement, the outstanding balance of the Extension Note will automatically convert into PubCo ordinary shares at $10.00 per share upon closing of the business combination, unless repaid earlier. The note was issued as an unregistered security under Section 4(a)(2) of the Securities Act, and the company furnished a press release announcing the new extension.